Non-Nicotine Agents for Smoking Cessation

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver,
Colorado80220

Purpose:

The primary objective of this study is to determine which is the better approach to smoking
cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine
replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.

Study summary:

This study is a two-arm open-label, randomized controlled trial of bupropion combined with
transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with
all subjects receiving a behavioral counseling program for smoking cessation.

Criteria:

Inclusion Criteria:
- Readiness to set a quit date in the next two weeks,
- Current smoking of at least 15 cigarettes a day
Exclusion Criteria:
- Current untreated depression or receiving treatment for depression,
- History of seizures, major head injury, or other predisposition for seizures

NCT ID:

NCT00108537

Primary Contact:

N/A

Backup Contact:

N/A

Location Contact:

Denver, Colorado 80220United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: December 13, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.